Table 3

Compliance and tolerance

Split-dose group
(n=892)
Day-before group
(n=555)
p Value
Compliance with product intake, n (%):<0.0001
 Whole dose (4 L)797(89.3)440 (79.3)
 At least 75% of product74 (8.3)97 (17.5)
 Less than 75% of product21 (2.4)18 (3.2)
Willingness to repeat the same preparation in the future, n (%)822 (92.2)439 (79.1)<0.0001
Quality of sleep, n (%)<0.0001
 Sleepless night19 (2.1)11 (2.0)
 Severe distress46 (5.5)43 (7.7)
 Moderate distress133 (14.8)160 (28.8)
 Mild/no distress694 (77.6)341 (61.5)
 Need for travel interruption, n (%)27 (3.0)8 (1.4)0.08
 Faecal incontinence, n (%)13 (1.5)5 (0.9)0.49